There are 1105 resources available
58O - Clinical efficacy, safety, and PK/PD from the first in human study of BM201, a TLR7/8 agonist
Presenter: Rutian Li
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Abstract
625O - Efficacy and safety of lucitanib (AL3810) in second or subsequent-line treatment of advanced recurrent or metastatic thymic carcinoma: A randomized, double-blind, placebo-controlled multicenter phase II trial
Presenter: Wentao Fang
Session: Proffered Paper session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Optimal care with immunotherapy in esophageal and gastric cancer
Presenter: Raghav Sundar
Session: Incorporating immunotherapy in gastrointestinal (GI) cancer
Resources:
Slides
Webcast
How to treat endometrial cancer according to molecular subtypes with and after immunotherapy
Presenter: David SP Tan
Session: New frontiers in the treatment of gynaecolagical malignancies
Resources:
Slides
Webcast
What to look forward to in the future of CAR T cell therapy
Presenter: Changsong Qi
Session: Cell and gene therapy for solid tumours: Coming to a bedside near you soon?
Resources:
Slides
Webcast
Bispecific antibodies in frontline treatment
Presenter: Michelle Poon
Session: Bispecific antibodies
Resources:
Slides
Webcast
Invited Discussant LBA8 and 625O
Presenter: Jordi Remon Masip
Session: Proffered Paper session: Thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant 57O and 58O
Presenter: Aaron Tan
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Slides
Webcast
Invited discussant 1O and 36O
Presenter: Lucia Del Mastro
Session: Proffered Paper session: Breast cancer
Resources:
Slides
Webcast
Immunotherapy for colorectal cancer: The winners and the losers thus far?
Presenter: Timothy Price
Session: Incorporating immunotherapy in gastrointestinal (GI) cancer
Resources:
Slides
Webcast